Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06186102Phase 2Active Not Recruiting

Polyamine Treatment in Elderly Patients With Coronary Artery Disease

Role: collaborator

NCT06909006Phase 3Not Yet Recruiting

Semaglutide Treatment in Type 1 Diabetes

Role: collaborator

NCT06903728Not ApplicableNot Yet Recruiting

National Trial of CGM in Pregnant Women With Type 2 Diabetes

Role: collaborator

All 3 trials loaded